Biology of cells and organisms
A1 – A30
- A1: Histological expression and function of complement molecules in ovarian cancer
- A2: Multi-scale modelling of oxygen, glucose, lactic acid and pH gradients in tumours
- A3: Tetrahydrobiopterin in regulation of tumour angiogenesis mediated by PI3K/Akt, eNOS and Ras pathway
- A4: Differential expression of genes in disseminated and metastatic tumour cells from patients with metastatic breast cancer
- A5: Tumour neovascularisation: lessons from precancerous stem cells
- A6: Neovascularisation in tumour-derived cancer stem cells: are current anti-angiogenic therapy trials facing serious challenge?
- A7: The role of hypoxia-induced p53 in apoptosis
- A8: Gen-Id and the case of mistaken identity
- A9: Choline metabolism in cellular senescence, quiescence and transformation: a 1H NMR based metabolomics study
- A10: The role of eIF4E phosphorylation by MNKs in the proliferation and survival of breast cancer cells
- A11: Lysophosphatidic acid-induced NF-kappaB activation is dependent on beta-arrestin 2
- A12: Sensitization of hypoxic tumour cells through inhibition of PARP is oxygen dependent and correlates with decreased homologous recombination
- A13: Differential phosphoproteomics of fibroblast growth factor signalling: identification of Src-mediated phosphorylation events
- A14: Loss of WWOX causes aberrant PKB/Akt signalling and enhanced survival in ovarian cancer cells.
- A15: Class switch recombination: consequence of the natural connection between transcription and recombination in mammalian cells?
- A16: Epigenetics in renal cell carcinoma: array-based approaches to CpG methylation profiling and candidate tumour suppressor gene identification
- A17: Regulation of AKT by DNA-PK mediates platinum resistance in ovarian cancer
- A18: Identification and characterisation of small molecule inhibitors of phosphatidylinositol-4-phosphate 5-kinase
- A19: Development of a novel in vivo dual fluorescence p53 activity reporter system
- A20: Roles of Rho GTPases in tumour angiogenesis and vessel establishment
- A21: Radiation-induced recruitment and phosphorylation of cohesin in human cells
- A22: Whole transcriptome amplification from single-cell amounts of total RNA or direct cell lysates and analysis by microarrays
- A23: Expression of the common fragile site tumour suppressor genes WWOX and FHIT is dysregulated following chemotherapy drug treatment
- A24: p53 prevents entry into mitosis with uncapped telomeres
- A25: Stat3 is activated upon amplification of fibroblast growth factor receptors
- A26: A systems biology approach to modelling cell-to-cell communication in cancer
- A27: Modification of p53 by SUMO 2/3 conjugation
- A28: Inhibition of MDM2: a safe strategy in the presence of mutant p53?
- A29: Use of nuclear export inhibitors to enhance responses to the anti-tumour agent TRAIL
- A30: Shedding light on estrogen receptor alpha-cofactor interactions
